Saakshi Medtech pays ₹2,360 fine for Q4FY26 filing delay

1 min read     Updated on 11 Jun 2026, 08:14 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Saakshi Medtech and Panels Limited settled a ₹2,360 penalty with the National Stock Exchange of India for a one-day delay in submitting its shareholding pattern for Q4FY26. The company attributed the delay to technical difficulties on the NEAPS portal and confirmed that the fine was paid on June 8, 2026, withdrawing a previous request for a waiver.

powered bylight_fuzz_icon
42599981

*this image is generated using AI for illustrative purposes only.

Saakshi Medtech & Panels has paid a total fine of ₹2,360 to the National Stock Exchange of India (NSE) following a one-day delay in filing its shareholding pattern for the quarter ended March 31, 2026. The payment, made on June 8, 2026, settles the penalty notice issued by the exchange under Regulation 31 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that it is not seeking a waiver for the fine, correcting an earlier erroneous submission.

The NSE issued the notice on May 14, 2026, citing non-compliance with the standard operating procedure for filing shareholding patterns. The exchange identified a one-day delay, resulting in a base fine of ₹2,000 and an additional GST of ₹360. The notice had warned that failure to pay the fine could lead to the freezing of promoter shareholdings and a shift in trading to the 'Trade for Trade' basis.

In its response submitted on June 10, 2026, the company stated that the delay was caused by an unforeseen technical issue on the NEAPS portal, which disrupted the upload process despite preparatory steps being taken within the prescribed timelines. The disclosure was eventually submitted on May 22, 2026. The Board of Directors has taken cognizance of the delay and directed the strengthening of internal compliance monitoring mechanisms to prevent recurrence.

Mrs. Mayuri Aniket Latkar, CFO and Whole-Time Director, signed the response confirming the payment via UTR No. YESME61590063483. The company assured the exchange of its continued cooperation and commitment to maintaining high standards of regulatory compliance.

Details of Penalty

Regulation Quarter Fine amount per day (₹) Days of non-compliance Fine amount (₹)
REGULATION 31(1) 31-Mar-2026 2000 1 2000
Total Fine 2000
GST @18% 360
Total 2360

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0PSK01027/60886ab2bb564a48.pdf

Historical Stock Returns for Saakshi Medtech & Panels

1 Day5 Days1 Month6 Months1 Year5 Years
-2.12%+0.31%+16.64%+83.26%+49.85%+92.47%

How will the company's planned strengthening of internal compliance mechanisms specifically address technical vulnerabilities in the NEAPS portal?

Will this technical glitch and subsequent penalty impact Saakshi Medtech's compliance rating or trigger any increased scrutiny from SEBI in the upcoming quarters?

Are there other listed entities facing similar NEAPS portal issues that might prompt a broader review of the exchange's filing infrastructure?

Saakshi Medtech & Panels
View Company Insights
View All News
like20
dislike

Saakshi Medtech shareholders approve capital increase at EGM

1 min read     Updated on 05 Jun 2026, 09:31 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Saakshi Medtech and Panels Limited received shareholder approval to increase its authorized capital and issue equity shares on a preferential basis during an EGM held on June 2, 2026. The resolutions passed with 13,520,900 votes in favor, representing 76.58% of total outstanding shares, with no votes against. The voting results were scrutinized by Jay Pandya & Associates and submitted to the National Stock Exchange of India Limited on June 4, 2026.

powered bylight_fuzz_icon
42001450

*this image is generated using AI for illustrative purposes only.

Saakshi Medtech and Panels Limited secured shareholder approval to increase its authorized capital and issue equity shares on a preferential basis during an Extra-Ordinary General Meeting (EGM) held on June 2, 2026. The resolutions were passed with a requisite majority, with 13,520,900 votes polled representing 76.58% of the total outstanding shares. There were no votes cast against any of the resolutions. Mrs. Mayuri Aniket Latkar, Chief Financial Officer and Whole-time Director, submitted the voting results to the National Stock Exchange of India Limited on June 4, 2026, under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting Results

The remote e-voting process was scrutinized by Jay Pandya, Proprietor of M/s. Jay Pandya & Associates, Company Secretaries. The voting period remained open from May 29, 2026, to June 1, 2026. The promoter group, holding 13,210,100 shares, participated fully via e-voting, while public shareholders also cast their votes through the remote e-voting facility.

Resolutions Passed

Sr. No. Particulars of Resolution Nature of Resolution Votes in Favor Votes Against
1. Increase in Authorized Capital and consequential alteration in the Capital Clause of Memorandum of Association Ordinary Resolution 13,520,900 0
2. Approval of issue of Equity Shares on Preferential Basis for consideration other than cash Special Resolution 13,520,900 0

Meeting Details

The EGM commenced at 03:00 P.M. and concluded at 03:19 P.M. on June 2, 2026. The company confirmed that neither the promoters nor the promoter group were interested in the agenda or resolutions presented. The results of the remote e-voting were announced within the stipulated timeframe and intimated to the stock exchanges.

Historical Stock Returns for Saakshi Medtech & Panels

1 Day5 Days1 Month6 Months1 Year5 Years
-2.12%+0.31%+16.64%+83.26%+49.85%+92.47%

What specific strategic acquisitions or investments does Saakshi Medtech plan to fund through the preferential issue of equity shares?

How will the dilution of existing shareholding impact the company's earnings per share and stock valuation in the short term?

Who are the potential investors likely to participate in the preferential allotment, and what expertise or value will they bring?

Saakshi Medtech & Panels
View Company Insights
View All News
like15
dislike

More News on Saakshi Medtech & Panels

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+49.85%